We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
64 hedge funds and large institutions have $288M invested in Flexion Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
354% more call options, than puts
Call options by funds: $4.67M | Put options by funds: $1.03M
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
22% more capital invested
Capital invested by funds: $235M → $288M (+$52.8M)
9% less funds holding
Funds holding: 70 → 64 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
28
Reduced
16
Closed
14
Calls
$4.67M
Puts
$1.03M
Net Calls
+$3.64M
Net Calls Change
-$1.14M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$9.11M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.52M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$2.55M |
| 4 |
JP Morgan Chase
New York
|
+$1.97M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.73M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$15.4M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.8M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.56M |
| 4 |
Morgan Stanley
New York
|
-$2.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.98M |
